XEJ.F Accuray Incorporated

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
0.1054 EUR
Close of Nov 13, 2026
3.10 37.40
Market cap
EUR 316K
P/E
-
P/B
0.27x
ROE
76.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Sep 2026.

Is XEJ.F undervalued?

Graham number

The Graham number of Accuray Incorporated cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Accuray Incorporated fundamental analysis

No fundamental analysis for Accuray Incorporated yet.

Accuray Incorporated stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Accuray Incorporated

Accuray Incorporated engages in the design, development, and sale of radiosurgery and radiation therapy systems for the treatment of tumors throughout the body in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside t…

Full company profile